RT @ThisaranaW: Pleased to have won the BTS Winter Meeting travel bursary award at the annual #EMTS conference today🫁@EMthoracic @leicsches….

RT @CersResearch: Our fabulous @GillianDoe1 won best oral presentation @EMthoracic conference yesterday on her work with @ArtiQHealth in us….

We are back with #EMTS2024 !.I missed the fascinating start with a session on respiratory infections but we are back after some brilliant poster sessions with our keynote from Gareth Walters on occupational lung disease

Tickets and abstract submission for our 2024 meeting are now available at Save the date 12th November 2024, abstract submission open until 30th September . #EMTS2024.

What do you want to know?.

In symposia we have @drkatyroach chairing and @amandatatler speaking in the BTS/BALR session, and @sarah_diver delivering an impressive talk on the microbiome in asthma in the Churchill room. #BTSWinter2023 #Respisbest.

Lots of East Midlands representation at #BTSwinter2023 this morning - @bolton_char chairing oral presentations on COVID recovery, with Hamish McCauley and @Omer_Elneima speaking. @AmandaTGoodwin is presenting the @TracheaNetwork AEILD observational study in the ILD session.

RT @KarenMarshall02: Here is the link about BreathTec for anyone who is interested. @EMthoracic.

RT @JeebunVandana: Goosebumps listening to the very inspirational @KarenMarshall02 today @EMthoracic on CBT and its significant impact on s….

RT @JeebunVandana: Privileged to be invited today to share my experience in navigational bronchoscopy @EMthoracic. Hope to have demystified….

RT @KarenMarshall02: @EMthoracic brilliant presentation by @JeebunVandana today at Loughborough. I learnt so much about the fantastic serv….

And finally our prize presentations:.1st spoken: Sarah Diver.2nd spoken: Zoe Shipley.1st poster: Helen Morgan. Congratulations to everyone and thanks for attending! See you next year #EMTS.

And some fascinating points on challenging aspects of changing care - multiple psychosocial issues, those that cannot yet access CFTR modulators and side effects of the medication.

There may be emerging evidence demonstrating the safety of reducing other CF treatments, attenuating the burden of these (including nearly two hours a day of time!).

Interesting point that one of the most appreciated effects by patients is reduction in cough - an exhausting and troublesome symptom.

Kaftrio in particular has truly revolutionised care, reducing the survival gap between CF and non CF by 82%. Median age of survival has gone from 40 to 66!.

Starting with a brief review of CF and the history of treatment developments, resulting in our novel personalised medications in CF: CFTR modulators.

And now our final talk of the day - Jane Dewar on new drugs in CF, AKA the Lazarus Effect!.

So yes, we do need to act smarter! This may involve smart inhalers, but more importantly communicate with patients, ensure they understand the necessity of treatment, identify barriers and concerns for the patient and simplify treatment as much as possible!.

Not much real life evidence yet, but this is something that will hopefully change soon.